1776 Wealth’s Pfizer PFE Stock Holding History

1776 Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,686	Closed	-$52K	–	260
2020 Q2	$52K	Sell	1,686 -2,465	-59%	-$83.7K	0.04%	188
2020 Q1	$139K	Buy	4,151 +2,305	+125%	+$78.5K	0.06%	163
2019 Q4	$68K	Buy	+1,846	New	+$65.8K	0.06%	158

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

1776 Wealth's PFE Position: Q3 2020 in Review

1776 Wealth sold out of Pfizer (PFE) in Q3 2020, closing a stake of 1,686 shares — an estimated $52K sold.

1776 Wealth first reported a position in PFE in Q4 2019 and held it in 3 quarters. The position peaked at $139K in Q1 2020. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

1776 Wealth reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
1776 Wealth sold 1,686 Pfizer shares in Q3 2020, an estimated $52K.
1776 Wealth first reported a position in Pfizer in Q4 2019 and held it in 3 quarters.
1776 Wealth's Pfizer position peaked at $139K in Q1 2020.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.